Ackerman John 4
Research Summary
AI-generated summary
Guardian Pharmacy (GRDN) Director John Ackerman Converts 1,884,996 Shares
What Happened
- John Ackerman, a director of Guardian Pharmacy Services, Inc. (GRDN), reported derivative transactions on 2026-03-28 that reflect the automatic conversion of his Class B common stock into Class A common stock. The filing shows conversions of 1,413,939 shares and 471,057 shares (total 1,884,996 shares) — recorded as dispositions of Class B and acquisitions of Class A. No cash price or dollar value is reported (price = N/A).
Key Details
- Transaction date: 2026-03-28; Form 4 filed: 2026-03-31 (filed within the typical 2-business-day window).
- Transaction code: M (exercise or conversion of derivative) — here used for the automatic Class B → Class A conversion.
- Shares converted: 1,413,939 and 471,057 (total 1,884,996), one-for-one conversion; price reported as N/A (no cash exchanged).
- Shares owned after transaction: not specified in the provided filing.
- Footnote: Per the company’s Amended and Restated Certificate of Incorporation, the Reporting Person’s Class B shares automatically convert to Class A on a one-for-one basis in substantially equal tranches on March 28, 2026 and September 27, 2026. This filing reports the March 28 tranche.
Context
- This was not a purchase or sale in the market but an automatic class conversion of existing shares, so it does not necessarily signal a change in insider sentiment. The Form 4 shows both disposition (of Class B) and acquisition (of Class A) lines because of the conversion mechanics.